IP Verse

Methods Of Using Pyruvate Kinase Activators

Patent No. EP3307271 (titled "Methods Of Using Pyruvate Kinase Activators") was filed by Agios Pharmaceuticals on Jun 10, 2016. The application was issued on Sep 13, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SANDOZJun 13, 2024TER MEER STEINMEISTER & PARTNER
BOTTI & FERRARIJun 11, 2024BOTTI & FERRARI

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3307271

AGIOS PHARMACEUTICALS
Application Number
EP16808374A
Filing Date
Jun 10, 2016
Status
Granted And Under Opposition
Aug 11, 2023
Publication Date
Sep 13, 2023
External Links
Slate, Register , Google Patents